Jayanta Das

Prof. Dr. Jayanta Das

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2018 in Cells
Verified
Journal Article
Open access
PDF file
JDJayanta Das
Jayanta Das
QFQuentin Felty
Quentin Felty
RPRobert Poppiti
Robert Poppiti
RJRobert M. Jackson
Robert M. Jackson
Deodutta RoyDeodutta Roy
Deodutta Roy
We have previously shown nuclear respiratory factor 1 (NRF1)-mediated transcriptional programming of mitobiogenesis contributes to estrogen-induced breast cancer through modulating cell cycle progression. In this study, we report a new role of NRF1 that goes beyond that of programming mitobiogenesis. Specifically, we report a novel oncogenic function of NRF1 supporting its causative role in breast cancer development and progression. The gain of NRF1 and/or treatment with 17β-estradiol (E2) produced heterogeneous breast cancer stem cell (BCSC)-like subsets composed of more than 10 distinct cell sub-populations. Flow sorting combined with confocal imaging of markers for pluripotency, epithelial mesenchymal transition (EMT), and BCSCs phenotypically confirmed that the BCSC-like subset arise from cell re-programming. Thus, we determined the molecular actions of NRF1 on its target gene CXCR4 because of its known role in the acquisition of the BCSC-like subset through EMT. CXCR4 was activated by NRF1 in a redox-dependent manner during malignant transformation. An NRF1-induced BCSC-like subset was able to form xenograft tumors in vivo, while inhibiting transcription of CXCR4 prevented xenograft tumor growth. Consistent with our observation of NRF1-driven breast tumorigenesis in the experimental model, higher protein levels of NRF1 were also found in human breast cancer tissue specimens. This highly novel role of NRF1 in the stochastic acquisition of BCSC-like subsets and their progression to a malignant phenotype may open an entirely new research direction targeting NRF1 signaling in invasive breast cancer. Our discovery of targeting transcriptional activation of CXCR4 to inhibit NRF1-induced oncogenic transformation provides a mechanistic explanation for estrogen-dependent breast carcinogenesis and opens new avenues in strategic therapeutics to fight breast cancer.

3 October 2011 in Physical Review B
Verified
Journal Article
Closed access
KMKrishnakumar S. R. Menon
Krishnakumar S. R. Menon
SMSuman Mandal
Suman Mandal
JDJayanta Das
Jayanta Das
TMTevfik Onur Menteş
Tevfik Onur Menteş
MNMiguel Angel Niño
Miguel Angel Niño
RBRachid Belkhou
Rachid Belkhou
We report on the surface antiferromagnetic (AFM) domain imaging of the prototype antiferromagnet NiO(100) using an electron-microscopy-based laboratory method. Coherently exchange-scattered electrons from the surface AFM lattice are utilized in a low-energy electron microscope to resolve the surface domain structure. Direct comparison with x-ray magnetic linear dichroism photoemission electron microscopy demonstrates a complimentary nature. High surface sensitivity combined with improved spatial resolution of this method enables studying of nanosized magnetic domains in NiO(100) thin films and their thickness-dependent evolution.

9 June 2022 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
JDJayanta Das
Jayanta Das
ADAlok Deoraj
Alok Deoraj
Deodutta RoyDeodutta Roy
Deodutta Roy
QFQuentin Felty
Quentin Felty

30 December 2021 in INTERNATIONAL JOURNAL OF EXPERIMENTAL RESEARCH AND REVIEW
Verified
Journal Article
Open access
PDF file
JDJayanta Das
Jayanta Das
MDMadhumita Das
Madhumita Das
MDMayur Doke
Mayur Doke
SWStanislaw Wnuk
Stanislaw Wnuk
RSRosy Mary Stiffin
Rosy Mary Stiffin
JCJonathan P. Celli
Jonathan P. Celli
Pancreatic cancer is the fourth highest cause of cancer-related deaths in the United States, with a projected 60,430 new cases diagnosed and 48,220 patients dying in 2021. We employed a small chemical, N-(6-Chloro-2-enzothiazolyl)-3, 4-dimethoxy-benzene propanamide (KY-02111), to target suppression of tumori-sphero-genesis of PANC1ORGRCD19+31+45+133+, to propose a novel therapeutic strategy against drug registrant pancreatic cancer stem cells (PANC1ORGRCD19+31+45+133+). According to our findings, the pancreatic stem cell indicators (CD19+31+45+133+) are found to be more strongly expressed in pancreatic cancer tissues than in normal pancreatic tissues.The flow cytometry, immunoblot and immunofluorescence analysis showed that the expression ofthese markers (CD19+31+45+133+) in PANC1ORGR spheroid cells was lowered by treatment of our new therapeutic approach. Therefore, this study identified the significant relationship of inhibition of tumori-sphero-genesis of PANC1ORGR with associated novel biomarkers (CD19+31+45+133+) which could be target candidates in designing drugs against pancreatic cancer. Further investigation and funding areneeded to find the molecular mechanism of inhibition of tumori-sphero-genesis by this small molecule. This work was partly used the financial support from award money of 2017 Translational Research Award, Society of Toxicology and 2018 AACR Minority and Minority-Serving Institution Faculty Scholar award of Dr. Jayanta K. Das.

26 December 2024 in Medical Sciences
Verified
Journal Article
Open access
PDF file
VAVincent Avecilla
Vincent Avecilla
MDMayur Doke
Mayur Doke
SASANDEEP APPUNNI
SANDEEP APPUNNI
Muni RubensMuni Rubens
Muni Rubens
VRVenkataraghavan Ramamoorthy
Venkataraghavan Ramamoorthy
JDJayanta Das
Jayanta Das
Vascular diseases, such as hypertension, atherosclerosis, cerebrovascular, and peripheral arterial diseases, present major clinical and public health challenges, largely due to their common underlying process: vascular remodeling. This process involves structural alterations in blood vessels, driven by a variety of molecular mechanisms. The inhibitor of DNA-binding/differentiation-3 (ID3), a crucial member of ID family of transcriptional regulators, has been identified as a key player in vascular biology, significantly impacting the progression of these diseases. This review explores the role of ID3 in vascular remodeling, emphasizing its involvement in processes such as apoptosis, cell proliferation, and extracellular matrix regulation. Furthermore, we examine how oxidative stress, intensified by exposure to estrogenic endocrine disruptors (EEDs) like polychlorinated biphenyls (PCBs) and bisphenol A (BPA), affects ID3 activity and contributes to vascular disease. Understanding the interaction between ID3 signaling and EED exposure provides critical insights into the molecular mechanisms underlying vascular remodeling and its role in the development and progression of vascular diseases.

Verified
Journal Article
Open access
PDF file
VAVincent Avecilla
Vincent Avecilla
MDMayur Doke
Mayur Doke
MDMadhumita Das
Madhumita Das
OAOscar Alcezar
Oscar Alcezar
SASANDEEP APPUNNI
SANDEEP APPUNNI
JDJayanta Das
Jayanta Das
Vascular diseases, including peripheral arterial disease (PAD), pulmonary arterial hypertension, and atherosclerosis, significantly impact global health due to their intricate relationship with vascular remodeling. This process, characterized by structural alterations in resistance vessels, is a hallmark of heightened vascular resistance seen in these disorders. The influence of environmental estrogenic endocrine disruptors (EEDs) on the vasculature suggests a potential exacerbation of these alterations. Our study employs an integrative approach, combining data mining with bioinformatics, to unravel the interactions between EEDs and vascular remodeling genes in the context of PAD. We explore the molecular dynamics by which EED exposure may alter vascular function in PAD patients. The investigation highlights the profound effect of EEDs on pivotal genes such as ID3, LY6E, FOS, PTP4A1, NAMPT, GADD45A, PDGF-BB, and NFKB, all of which play significant roles in PAD pathophysiology. The insights gained from our study enhance the understanding of genomic alterations induced by EEDs in vascular remodeling processes. Such knowledge is invaluable for developing strategies to prevent and manage vascular diseases, potentially mitigating the impact of harmful environmental pollutants like EEDs on conditions such as PAD.